The Alliance welcomes inquiries from the media and offers its expertise for comment on new developments in ovarian cancer. All media inquiries should be directed to:
Faryl Greller (202) 331-1332 x 307 fgreller@ovariancancer.org
News Releases
Campaign call for ovarian cancer (BBC News)
Grant System Leads Cancer Researchers to Play It Safe (New York Times)
CDC Releases New Guidance on Genetic Testing (CDC)
Turning active after cancer (HHS HealthBeat)
Race does not impact outcome for advanced ovarian cancer patients treated with cisplatin/paclitaxel (Stanford's Highwire Press)
Routine follow-up after treatment for ovarian cancer in the United Kingdom (Stanford's Highwire Press)
New Cancer Drug Fights Tumors in Those With BRCA Mutations (Forbes)
Phase II randomized study of trabectedin for patients with relapsed, platinum-sensitive, advanced ovarian cancer (Annals of Oncology)
Ovarian Cancer National Alliance and Facing Our Risk of Cancer Empowered (FORCE) Welcome Continued Research about PARP inhibitors
The Ovarian Cancer National Alliance Invited to Testify on Capitol Hill
Cancer Treatment Centers Of America Studies Treatment That Aims Chemotherapy Directly At Ovarian Cancer Cells (Medical News Today)
CA125 Monitoring in the Management of Recurrent Ovarian Cancer (Gynecologic Oncology of Canada)
Advocates Urge Swift Passage of Johanna's Law: The Gynecologic Cancer Education and Awareness Act
Genetic Clue to Rare Ovarian Cancers Found (NCI)
Cancer patient tells of rips in health insurance safety net (CNN)